Program-Rome-2018

8:00 – 8:45

Registration and Morning Coffee

8:45 – 09:00

Welcome – Opening Ceremony

9:00 -10:30

Setting the Scene: Basic Understanding of Keloid Disorder

Michael H. Tirgan, MD

Clinical Presentation of Keloid Disorder; A Retrospective Study of 1088 Patients and Recommendation for Keloid Staging System.

Ernst Reichenberger, PhD

Genetics of Keloid Disorder

Frank Niessen, MD, PhD

Different properties of skin of different body sites: The root of keloid formation?

Xiao Long, MD

A comparison of apoptosis levels in keloid tissue, physiological scars and normal skin.

Bernard Veekmans, MD

Psycho-Social Impact of Keloid Disorder

Jonel May Breytenbach, MD

Clinical Case Presentation: Ear Keloid in a Patient with Albinism

Q/A

10:30-11:00

Coffee Break

11:00 -12:30

Basic Science of Keloid Disorder

Dorothy Supp, PhD

Progress in Keloid Animal Models

Gwenaël Rolin, PhD

From Experimental Data to a Numerical Model of “Keloid-Surrounding Skin” Composite Structure

Shirley Brody Russell, PhD

Gene expression in keloids and pleiotropic effects of risk factors for fibroproliferative disease

Ferdinand Nangole, MD

Keloids: Proliferative or Inflammatory disorder?

Scott MacDonnell, PhD

Advancing the Study of Keloids with In-Vitro Modeling and Single-Cell Sequencing

Mark Fear, PhD

Changes to Fibroblast Phenotype in Keloid Disorder

Q/A

12:30 – 13:30

Lunch Break

12:30 – 13:30

Special Session:

Keloid Nomenclature Working Group: Aiming to Harmonize Definitions and to Adopt Standard Nomenclature. This Session is Open to all Participants.

13:30 -15:00

Role of Surgery in Treatment of Keloid Lesions

Tae Hwan Park, MD, PhD

Optimization of Surgical Management for the Treatment of Auricular Keloids

Frank Niessen, MD, PhD

Intralesional Surgery in Combination with Contact Cryotherapy

Jürg Hafner, MD

A Dermatologic Surgeon’s Approach to Keloids

Wang Youbin, MD

Subcutaneous Surgical Resection of Keloid Lesions

Xiao Long, MD

Algorithm for Treatment of Chest Wall Keloids. Report of a large study from Peking Union Medical College Hospital

Young-Jun Choi, MD

Auricular Keloid Management: Clinical Outcome of Intralesional Excision and Postoperative Triamcinolone Acetonide Intralesional Injection

Q/A

Tae Hwan Park, MD, PhD

Clinical Case Presentation: Usefulness of Keystone flap in Keloid Surgery

15:00 – 15:30

Coffee break, poster viewing & exhibition

15:30: 17:00

Role of Radiation Therapy in Treatment of Keloid Lesions

Jonathan Tsao, MD

Overview of Adjuvant Radiation Therapy in Management of Keloid Lesions

John Glees, MD, FRCR, DMRT

Four Decades of Experience with Radiation Therapy in Treating Keloid Lesions at the Royal Marsden Hospital, London, St George’s University Hospital, London and Cancer Centre London. Current Procedures and Potential for Future Developments

Henry Weatherburn, PhD

Estimates of Radiation Risks Arising from the Treatment of Keloids by Radiotherapy

Xiao Long, MD

Hypo-fractionated Electron Beam Radiation Therapy, a Retrospective Analysis of 568 Keloid Patient with 834 Keloid Lesions

Ioannis Goutos, FRCSEd (Plast)

Brachytherapy as an Adjunct in the Management of Keloid Lesions

Jonathan Tsao, MD

Treating Keloids with Adjuvant High-Dose Rate Brachytherapy, a Canadian Experience

17:30 – 18:30

Reception

18:30- 19:30

Walk to La Campana

Everyone is invited

19:30 – 22:30

Dinner at La Campana

Everyone is invited

7:30 – 8:45

Registration and Morning Coffee

8:45 -10:30

Non-Surgical Management of Keloid Lesions

Reza Ghohestani, MD, PhD

Role of Lasers and Light-based Devices in Treatment of Keloids: When, Where and How?

Lennert Van Putte, MD

Abstract Presentation: Intralesional Steroids – Efficacy and Potential Adverse Effects

Angela Filoni, MD

Abstract Presentation: 595nm Pulsed Dye Laser For Hypetrophic and Keloid Scars Treatment. A Randomized-Controlled Study

Michael H Tirgan, MD

Role of Cryotherapy in Treatment of Bulky Keloids.

Sofie De Schrijver, MD

Abstract Presentation: Painful Keloids. Evaluation of Risk Factors and Recommendation for Treatment

Ioannis Goutos, FRCSEd (Plast)

Steroid tape as an Adjunct in the Management of Keloid and Hypertrophic Scars

Wang XiQiao, MD

Clinical Case Presentation: Earlobe Keloid Regression by Bottom Ligature and Injection with Corticosteroid and 5-FU

Q/A

10:30-11:00

Coffee Break

11:00 – 12:30

Basic Science Research / Abstract Presentation

Shirley Brody Russell, PhD

Admixture mapping and increased risk factors for fibrosis in African ancestry populations

Lamont Jones, MD, MBA

The MicroRNA Methylome Landscape in Keloid Pathogenesis

Haythem Y. Ali, MD

Can anomalies of the Atypical Chemokine Receptor 1 (ACKR1) gene explain the dysregulated microenvironment of keloids and some aggressive breast cancer subtypes?

Maria Worsham, PhD

Canvassing tissue microenvironments for immune disease markers as potential candidates of immunotherapy responsiveness: applicability to keloid pathogenesis”.

David Yeo, PhD

Micro/Nanotechnology for diagnosis and treatment of keloids and hypertrophic scars.

Frank B. Niessen, MD, PhD

Early inflammatory differences between normotrophic and hypertrophic scars in humans

Q/A

12:30 – 13:30

Lunch Break

12:30 – 13:30

Special Session:

Jürg Hafner, MD

Keloid Clinical Trial Working Group – Randomized Study of Surgery v. Cryotherapy in Patients with Ear Keloids. This Session is Open to all Participants.

13:30 – 15:00

Clinical Research Session / Abstract Presentation

Tae Hwan Park, MD PhD

Could -79 °C Spray-Type Cryotherapy Be an Effective Monotherapy for the Treatment of Keloid?

Wang Youbin, MD

Study of Hyperbaric Oxygen Treatment in Keloid Patients

Reza Ghohestani, MD PhD

Efficacy of a Multimodal Approach for treatment of Keloids

Lamont Jones, MD, MBA

The Effects of Post-Operative Intralesional Corticosteroids in the Prevention of Recurrent Earlobe Keloids: A Multispecialty Retrospective Review

Gwenaël Rolin, PhD

Multiscale analysis of a keloid by imaging and biomechanical devices

Daniel Cassuto, MD

Clinical Abstract Presentation: Use of pneumatic needle-free injection technology for treatment of keloid scars in adult patients

Q/A

15:00 – 15:30

Coffee break

15:30: 17:00

Vision / Future of Keloid Research

Swee Tan, MBBS FRACS PhD

Embryonic Stem Cell-Like Population within KALTS in Keloid Scar Expresses Components of the Renin-angiotensin System and Cathepsins B, D and G.

Peter Temple-Smith, PhD

Deactivating activin: a new direction in the treatment of keloids

Dorothy Supp, PhD

Vitamin D Receptor Expression in Keloids

Gwenaël Rolin, PhD

Halofuginone vs TGF-Mediated Fibrosis: in Vitro Investigations on Site-Specific Keloid Fibroblasts

Ofir Artzi, MD

THE KELOIDS BANE, WITHOUT THE PAIN – A New Approach in the Treatment of Keloids: Tixel-Associated topical Triamcinolone acetonide and 5-fluorouracil delivery

Closing Remarks- Open discussion

17:00 – 18:30

Reception